EFPIA - NEWSLETTER

EFPIA Newsletter 23 March 2023

News

20 March 2023 New European legislation designed to protect patients is delaying clinical trials for thousands...

The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the...

21 March 2023 EU long-term competitiveness strategy has to apply to the EU Pharma legislation

We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver...

Blogs

21 March 2023 Why pull incentives are key to catalysing private investment into antibiotics

The advent of antibiotics was one of the fundamental drivers of the shift in health care that has dramatically increased...

Events

24 APR 2023

Strengthening European health systems Online

How to invest in innovation while driving efficiencies.

Learn more →

30 MAR 2023

The Estimands Academy for Trial Teams: Bringing estimands to life through case studies... Online

Webinar 4 - Proposing Estimands from Different Perspectives: Patient, Clinician, Regulator, Health Technology Assessor...

Learn more →

We published

Regulatory Road to Innovation Experts' Insights 22 March 2023 (Publications)

How can we work together to create a world-class 21st century regulatory framework to deliver safer, better medicines...

What we are reading

EU pharma reform delayed again due to Commission’s busy agenda 22 March 2023 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶